Drug Safety Labeling

  • Goals: Determine if, under typical home-lighting conditions, patients with metabolic disease would be able to differentiate between multiple concentrations of a new injection medication intended for home-use, and if they would be able to differentiate the prescribed medication from other pre-filled syringes currently on the market
  • Method: Participants with a diagnosis of metabolic disease, with an included subsample quota for comorbidity of diabetes, and an additional small number of individuals with color vision deficiency, completed tasks related to differentiating medications in a simulated home environment
  • Results: Results indicated that patients would be able to safely differentiate between dosages and other pre-filled syringes

Representative medical cabinets with syringes used in testing